SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Houman, M H
Right arrow Articles by Miled, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Houman, M H
Right arrow Articles by Miled, M
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Systemic lupus erythematosus in Tunisia: demographic and clinical analysis of 100 patients

M H Houman

Department of Internal Medicine, La Rabta University Hospital, Tunis, Tunisia, houman.habib{at}rns.tn

M Smiti-Khanfir

Department of Internal Medicine, La Rabta University Hospital, Tunis, Tunisia

I Ben Ghorbell

Department of Internal Medicine, La Rabta University Hospital, Tunis, Tunisia

M Miled

Department of Internal Medicine, La Rabta University Hospital, Tunis, Tunisia

There is a wide variationin the natural history of systemic lupus erythematosus(SLE) among different ethnic and geographicalgroups. Studies in Arabs are few and those in North Africans and especiallyin the Tunisian population do not exist. This study aims to demonstrate the demographic, clinical and laboratory characteristics of SLE Tunisian patients and to identify those at high risk for renal and neuropsychiatricinvolvements. One hundred patients with SLE (American College of Rheumatology criteria), seen at the Department of Internal Medicine of the University Hospital La Rabta in Tunisia over a 15-year period (1987 to 2001) were retrospectivelyenrolled. There were 92 women and eight men with an average age at the onset of disease of 32 years. Nineteen patients were aged over 50 years at the moment of SLE diagnosis(late-onsetSLE). Of the patients,78% had articularinvolvement,53% photosensitivityand 63% malar rash. Serositis occurred in 45 patients of whom 16 had pericarditisand 29 had pleuritis. Nephritis was diagnosed in 43% of the cases and consisted always of glomerular nephritis, in three cases of which tubulointerstitiallesions were also observed. Comparison of patients with and without renal involvement showed that lupus nephritis was significantly associated with pericarditis (P 0.03), arterial blood hypertension (P < 0.0001), cryoglobulinemia (P 0.07) and antiphospholipid syndrome (P 0.03). The SLEDAI at SLE diagnosis was significantly higher for lupus nephritis patients. Twelve patients with lupus nephritis died compared with three patients in the remaining group (P < 0.0001). Neuropsychiatric manifestations were observed in 25% of the cases. The mean age at SLE onset was significantly lower, the mean SLEDAI at SLE diagnosis and the mortality were significantly higher in the neuropsychiatric group than in the remaining group. Immunological features included antinuclear antibodies (100%), anti-DNA antibodies (56%), anti-Sm antibodies (61%), anticardiolipin antibodies (62%), anti-b2GP1 (13%) anti-Rnp (23%) and hypocomplementemia (48%). The frequencies of pulmonary hypertension (25 versus 2%, P < 0.00001) and vascular thrombosis (25 versus 2%, P < 0.00001) were significantly higher in patients with positive anti b2GPI antibodies. The five-year survival rate in our series was 86%. The most frequent causes of death were active SLE and infections.

Key Words: Arab African • autoantibodies • demographics • nephritis • outcome • systemic lupus erythematosus

Lupus, Vol. 13, No. 3, 204-211 (2004)
DOI: 10.1191/0961203303lu530xx


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
LupusHome page
A. Al Arfaj and N Khalil
Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia
Lupus, April 1, 2009; 18(5): 465 - 473.
[Abstract] [PDF]


Home page
LupusHome page
J. AlSaleh, V. Jassim, M. ElSayed, N. Saleh, and D. Harb
Clinical and immunological manifestations in 151 SLE patients living in Dubai
Lupus, January 1, 2008; 17(1): 62 - 66.
[Abstract] [PDF]


Home page
LupusHome page
T. Heller, M. Ahmed, A. Siddiqqi, C. Wallrauch, and S. Bahlas
Systemic lupus erythematosus in Saudi Arabia: morbidity and mortality in a multiethnic population
Lupus, November 1, 2007; 16(11): 908 - 914.
[Abstract] [PDF]


Home page
LupusHome page
H. Al-Rayes, R. Al-Swailem, M. Arfin, S. Sobki, S. Rizvi, and M. Tariq
Lupus Around the World: Systemic lupus erythematosus and infections: a retrospective study in Saudis
Lupus, September 1, 2007; 16(9): 755 - 763.
[Abstract] [PDF]


Home page
Rheumatology (Oxford)Home page
S. Wadee, M. Tikly, and M. Hopley
Causes and predictors of death in South Africans with systemic lupus erythematosus
Rheumatology, September 1, 2007; 46(9): 1487 - 1491.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
L M Vila, M J Molina, A M Mayor, R A Peredo, M L Santaella, and S Vila
Clinical and prognostic value of autoantibodies in Puerto Ricans with systemic lupus erythematosus
Lupus, December 1, 2006; 15(12): 892 - 898.
[Abstract] [PDF]


Home page
LupusHome page
C S Lau, G Yin, and M Y Mok
Ethnic and geographical differences in systemic lupus erythematosus: an overview
Lupus, November 1, 2006; 15(11): 715 - 719.
[Abstract] [PDF]


Home page
LupusHome page
Y W Park, H Woo, Y Y Jeong, J H Lee, J J Park, and S S Lee
Association of nodular regenerative hyperplasia of the liver with porto-pulmonary hypertension in a patient with systemic lupus erythematosus
Lupus, October 1, 2006; 15(10): 686 - 688.
[Abstract] [PDF]


Home page
LupusHome page
M Govoni, G Castellino, S Bosi, N Napoli, and F Trotta
Incidence and prevalence of systemic lupus erythematosus in a district of North Italy
Lupus, February 1, 2006; 15(2): 110 - 113.
[Abstract] [PDF]


Home page
Ann Rheum DisHome page
I Uthman and M Khamashta
Ethnic and geographical variation in antiphospholipid (Hughes) syndrome
Ann Rheum Dis, December 1, 2005; 64(12): 1671 - 1676.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
G Ibtissem
Letter to the Editor
Lupus, February 1, 2005; 14(2): 170 - 170.
[PDF]



Advertisement